Phase II study of weekly paclitaxel as a second-line treatment for S-1-refractory advanced gastric cancer.
Matsuda G, Kunisaki C, Makino H, Fukahori M, Kimura J, Sato T, Oshima T, Nagano Y, Fuii S, Takagawa R, Kosaka T, Ono HA, Akiyama H, Ichikawa Y.
Matsuda G, et al. Among authors: ichikawa y.
Anticancer Res. 2009 Jul;29(7):2863-7.
Anticancer Res. 2009.
PMID: 19596975
Free article.
Clinical Trial.